AnaptysBio
ANAB
ANAB
136 hedge funds and large institutions have $601M invested in AnaptysBio in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 45 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
4.48% less ownership
Funds ownership: 106.66% → 102.18% (-4.5%)
20% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 45
Holders
136
Holding in Top 10
5
Calls
$4.6M
Puts
$1.67M
Top Buyers
| 1 | +$25.7M | |
| 2 | +$16.3M | |
| 3 | +$7.16M | |
| 4 |
GA
Greenspring Associates
Owings Mills,
Maryland
|
+$3.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.36M |
Top Sellers
| 1 | -$30.5M | |
| 2 | -$18.1M | |
| 3 | -$7.76M | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$5.63M |
| 5 |
BCM
Burrage Capital Management
Boston,
Massachusetts
|
-$4.88M |